AnaptysBio (NASDAQ: ANAB)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AnaptysBio (NASDAQ: ANAB) through any online brokerage.
Other companies in AnaptysBio’s space includes: Immunovant (NASDAQ:IMVT), Immatics (NASDAQ:IMTX), Inovio Pharmaceuticals (NASDAQ:INO), Pharming (NASDAQ:PHAR) and Adicet Bio (NASDAQ:ACET).
The latest price target for AnaptysBio (NASDAQ: ANAB) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting ANAB to fall to within 12 months (a possible -84.75% downside). 50 analyst firms have reported ratings in the last year.
The stock price for AnaptysBio (NASDAQ: ANAB) is $26.23 last updated August 12, 2022, 8:00 PM UTC.
The next AnaptysBio (ANAB) dividend date is projected to be Thursday, September 1, 2022.
AnaptysBio’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for AnaptysBio.
AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.